Mu‐Sheng Zeng

20.0k total citations · 1 hit paper
297 papers, 11.7k citations indexed

About

Mu‐Sheng Zeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mu‐Sheng Zeng has authored 297 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 145 papers in Oncology and 69 papers in Cancer Research. Recurrent topics in Mu‐Sheng Zeng's work include Viral-associated cancers and disorders (72 papers), RNA modifications and cancer (40 papers) and Cancer-related molecular mechanisms research (37 papers). Mu‐Sheng Zeng is often cited by papers focused on Viral-associated cancers and disorders (72 papers), RNA modifications and cancer (40 papers) and Cancer-related molecular mechanisms research (37 papers). Mu‐Sheng Zeng collaborates with scholars based in China, United States and Hong Kong. Mu‐Sheng Zeng's co-authors include Man-Zhi Li, Li-Bing Song, Erwei Song, Yi-Xin Zeng, Qian Zhong, Wenting Liao, Qiang Liu, Mengfeng Li, Jian‐Yong Shao and Fengxi Su and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Mu‐Sheng Zeng

287 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis

2015 746 citations Qiang Liu, Yandan Yao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mu‐Sheng Zeng China	57	6.8k	4.2k	4.0k	1.6k	1.1k	297	11.7k
Yi-Xin Zeng China	59	6.8k 1.0×	3.6k 0.9×	3.8k 1.0×	1.8k 1.1×	945 0.8×	183	11.3k
Kwok Wai Lo Hong Kong	65	7.4k 1.1×	6.5k 1.5×	4.4k 1.1×	1.5k 0.9×	1.4k 1.2×	265	14.6k
Daniel E. Johnson United States	46	8.4k 1.2×	4.3k 1.0×	2.3k 0.6×	2.2k 1.3×	737 0.6×	133	13.6k
Ya Cao China	58	7.2k 1.1×	3.9k 0.9×	4.7k 1.2×	2.2k 1.4×	1.3k 1.1×	311	12.6k
Alexandra Giatromanolaki Greece	65	7.6k 1.1×	4.2k 1.0×	5.9k 1.5×	2.0k 1.2×	1.6k 1.4×	389	15.3k
Walter N. Hittelman United States	62	7.4k 1.1×	3.8k 0.9×	2.5k 0.6×	984 0.6×	465 0.4×	223	12.2k
Tim Crook United Kingdom	54	6.5k 0.9×	5.2k 1.2×	2.3k 0.6×	1.0k 0.6×	2.4k 2.1×	120	11.1k
Francesco Pezzella United Kingdom	58	7.0k 1.0×	4.1k 1.0×	4.5k 1.1×	1.4k 0.9×	682 0.6×	159	12.1k
Efthimios Sivridis Greece	55	5.2k 0.8×	2.6k 0.6×	4.3k 1.1×	953 0.6×	1.3k 1.1×	245	10.2k
Philip J. Coates United Kingdom	49	4.5k 0.6×	3.1k 0.7×	1.3k 0.3×	1.0k 0.6×	861 0.8×	205	9.4k

Countries citing papers authored by Mu‐Sheng Zeng

Since Specialization

Citations

This map shows the geographic impact of Mu‐Sheng Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐Sheng Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐Sheng Zeng more than expected).

Fields of papers citing papers by Mu‐Sheng Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu‐Sheng Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐Sheng Zeng. The network helps show where Mu‐Sheng Zeng may publish in the future.

Co-authorship network of co-authors of Mu‐Sheng Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Mu‐Sheng Zeng. A scholar is included among the top collaborators of Mu‐Sheng Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu‐Sheng Zeng. Mu‐Sheng Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Wanlin, Rui Xiao, Qian Wu, et al.. (2025). A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection In Vitro and In Vivo. ACS Applied Materials & Interfaces. 17(18). 26252–26262. 1 indexed citations

Sun, Cong, Yan Wang, Yan Zeng, et al.. (2023). Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis. Science Advances. 9(21). eadg1778–eadg1778. 20 indexed citations

Sun, Cong, Chu Xie, & Mu‐Sheng Zeng. (2023). Breakthrough for Epstein-Barr virus vaccine development: gB nanoparticle vaccine. Chinese Science Bulletin (Chinese Version). 1 indexed citations

Hong, Junping, L. Zhong, Qingbing Zheng, et al.. (2022). A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo. Journal of Virology. 96(8). e0007522–e0007522. 12 indexed citations

Zhu, Nannan, et al.. (2022). Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties. Journal of Virology. 96(5). 13 indexed citations

Jiang, Chen, Lei Li, Yan‐Qun Xiang, et al.. (2020). Epstein–Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3. Cancer Research. 80(10). 1957–1969. 33 indexed citations

He, Yi, Yu Wang, Xueping Wang, et al.. (2020). Applying CRISPR/Cas13 to Construct Exosomal PD‐L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy. Advanced Therapeutics. 3(10). 34 indexed citations

Wang, Hongbo, Yun‐Jia Zhu, Lijuan Hu, et al.. (2020). Internal Ribosome Entry Sites Mediate Cap-Independent Translation of Bmi1 in Nasopharyngeal Carcinoma. Frontiers in Oncology. 10. 1678–1678. 2 indexed citations

Zhang, Ao, Junji Xing, Tianliang Xia, et al.. (2020). EphA2 phosphorylates NLRP 3 and inhibits inflammasomes in airway epithelial cells. EMBO Reports. 21(7). e49666–e49666. 32 indexed citations

10.

Feng, Guo‐Kai, Mengqing Zhang, Hongxia Wang, et al.. (2019). Identification of an Integrin α6‐Targeted Peptide for Nasopharyngeal Carcinoma‐Specific Nanotherapeutics. Advanced Therapeutics. 2(7). 24 indexed citations

11.

Huang, Di, et al.. (2017). Epstein–Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages. Cancer Research. 77(13). 3591–3604. 71 indexed citations

12.

Cai, Junchao, Lishan Fang, Yongbo Huang, et al.. (2017). Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nature Communications. 8(1). 15870–15870. 148 indexed citations

13.

Hu, Bingbing, Mu‐Sheng Zeng, Jingli Chen, et al.. (2016). External Magnetic Field‐Induced Targeted Delivery of Highly Sensitive Iron Oxide Nanocubes for MRI of Myocardial Infarction. Small. 12(34). 4707–4712. 21 indexed citations

14.

Xu, Ya-Fei, Xianyue Ren, Ying-Qin Li, et al.. (2015). High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma. BMC Cancer. 15(1). 332–332. 26 indexed citations

15.

Feng, Guo‐Kai, Qian Zhong, Yun-Fei Xia, et al.. (2014). SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide. Journal of Controlled Release. 192. 236–242. 32 indexed citations

16.

Zheng, Xin, Shan Xing, Wen Liu, et al.. (2014). Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer. 14(1). 490–490. 37 indexed citations

17.

Yao, Yandan, Tianmeng Sun, Songyin Huang, et al.. (2012). Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 ⁺ Breast Cancer Growth and Metastasis. Science Translational Medicine. 4(130). 130ra48–130ra48. 163 indexed citations

18.

Zhang, Yan, Li‐Xu Yan, Qi-Nian Wu, et al.. (2011). miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer. Cancer Research. 71(10). 3552–3562. 237 indexed citations

19.

Li, Wen, Ling Zhang, Qingli Kong, et al.. (2009). Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients. Clinical Cancer Research. 15(4). 1393–1399. 167 indexed citations

20.

Guo, Weijian, Mu‐Sheng Zeng, Ajay K. Yadav, et al.. (2007). Mel-18 Acts as a Tumor Suppressor by Repressing Bmi-1 Expression and Down-regulating Akt Activity in Breast Cancer Cells. Cancer Research. 67(11). 5083–5089. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact